This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Cytolynx Therapeutics Hong Kong Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yuhao Hu: Innovator in Monoclonal Antibody Development
Introduction
Yuhao Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Yuhao Hu holds a patent titled "Humanized Monoclonal Antibody Targeting BCMA and Having Human Monkey Cross-Reactivity." This patent reflects his expertise in creating targeted therapies that can enhance treatment efficacy.
Career Highlights
Yuhao Hu is currently employed at Cytolynx Therapeutics Hong Kong Limited, where he continues to advance his research and development efforts. His work at Cytolynx Therapeutics focuses on innovative solutions in the field of antibody therapeutics.
Collaborations
Yuhao has collaborated with notable colleagues, including Ning Li and Guoqing Cao. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Yuhao Hu's contributions to monoclonal antibody research exemplify the innovative spirit of modern biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.